{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T14:33:08Z","timestamp":1782311588689,"version":"3.54.5"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["Z01-ES-101986"],"award-info":[{"award-number":["Z01-ES-101986"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS082151"],"award-info":[{"award-number":["NS082151"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["ES019672"],"award-info":[{"award-number":["ES019672"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Penn State College of Medicine Translational Brain Research Center"},{"DOI":"10.13039\/100007709","name":"Michigan State University","doi-asserted-by":"publisher","award":["GE100455"],"award-info":[{"award-number":["GE100455"]}],"id":[{"id":"10.13039\/100007709","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013301","name":"Parkinson's Foundation","doi-asserted-by":"publisher","award":["PF-IMP-1825"],"award-info":[{"award-number":["PF-IMP-1825"]}],"id":[{"id":"10.13039\/100013301","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Parkinson\u2019s Research Program","award":["W81XWH-17-1-0536"],"award-info":[{"award-number":["W81XWH-17-1-0536"]}]},{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["R01ES029227"],"award-info":[{"award-number":["R01ES029227"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","prd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.parkreldis.2020.02.001","type":"journal-article","created":{"date-parts":[[2020,2,11]],"date-time":"2020-02-11T16:36:53Z","timestamp":1581439013000},"page":"23-30","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Non-motor symptoms and striatal dopamine transporter binding in early Parkinson's disease"],"prefix":"10.1016","volume":"72","author":[{"given":"Rui","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Umbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander I.","family":"Tr\u00f6ster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honglei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.parkreldis.2020.02.001_bib1","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/mds.24985","article-title":"Defining at-risk populations for Parkinson's disease: lessons from ongoing studies","volume":"27","author":"Berg","year":"2012","journal-title":"Mov. Disord."},{"issue":"12","key":"10.1016\/j.parkreldis.2020.02.001_bib2","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/nrneurol.2014.205","article-title":"Neuroimaging in Parkinson disease: from research setting to clinical practice","volume":"10","author":"Politis","year":"2014","journal-title":"Nat. Rev. Neurol."},{"issue":"4","key":"10.1016\/j.parkreldis.2020.02.001_bib3","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/1531-8257(200007)15:4<692::AID-MDS1014>3.0.CO;2-V","article-title":"Correlation of Parkinson's disease severity and duration with 123I-FP-CIT SPECT striatal uptake","volume":"15","author":"Benamer","year":"2000","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2020.02.001_bib4","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1002\/mds.26431","article-title":"MDS research criteria for prodromal Parkinson's disease","volume":"30","author":"Berg","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2020.02.001_bib5","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1212\/01.WNL.0000161874.52302.5D","article-title":"[99mTc]TRODAT-1 SPECT imaging correlates with odor identification in early Parkinson disease","volume":"64","author":"Siderowf","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2020.02.001_bib6","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jns.2011.06.020","article-title":"Motor and non-motor correlates of olfactory dysfunction in Parkinson's disease","volume":"310","author":"Berendse","year":"2011","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.parkreldis.2020.02.001_bib7","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/mds.26373","article-title":"Cognition in individuals at risk for Parkinson's: Parkinson associated risk syndrome (PARS) study findings","volume":"31","author":"Chahine","year":"2016","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2020.02.001_bib8","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.pneurobio.2011.09.005","article-title":"The Parkinson progression marker initiative (PPMI)","volume":"95","author":"Marek","year":"2011","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.parkreldis.2020.02.001_bib9","first-page":"753","article-title":"One-day protocol for imaging of the nigrostriatal dopaminergic pathway in Parkinson's disease by [123I]FPCIT SPECT","volume":"40","author":"Booij","year":"1999","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.parkreldis.2020.02.001_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2047-9158-4-1","article-title":"Meta-analyses on prevalence of selected Parkinson's nonmotor symptoms before and after diagnosis","volume":"4","author":"Chen","year":"2015","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.parkreldis.2020.02.001_bib11","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S1474-4422(11)70152-1","article-title":"Serial dopamine transporter imaging of nigrostriatal function in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study","volume":"10","author":"Iranzo","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.parkreldis.2020.02.001_bib12","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1093\/brain\/awh322","article-title":"Combination of 'idiopathic' REM sleep behaviour disorder and olfactory dysfunction as possible indicator for alpha-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT","volume":"128","author":"Stiasny-Kolster","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2020.02.001_bib13","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1002\/mds.26605","article-title":"Neuropathological basis of nonmotor manifestations of Parkinson\u2019s disease","volume":"31","author":"Adler","year":"2016","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2020.02.001_bib14","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/mds.24996","article-title":"Identifying prodromal Parkinson's disease: pre-motor disorders in Parkinson's disease","volume":"27","author":"Postuma","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2020.02.001_bib15","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/S1474-4422(10)70216-7","article-title":"Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study [corrected]","volume":"9","author":"Iranzo","year":"2010","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.parkreldis.2020.02.001_bib16","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S1474-4422(13)70056-5","article-title":"Neurodegenerative disease status and post-mortem pathology in idiopathic rapid-eye-movement sleep behaviour disorder: an observational cohort study","volume":"12","author":"Iranzo","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.parkreldis.2020.02.001_bib17","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1136\/jnnp.2009.183715","article-title":"Olfactory testing combined with dopamine transporter imaging as a method to detect prodromal Parkinson's disease","volume":"81","author":"Ponsen","year":"2010","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.parkreldis.2020.02.001_bib18","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1001\/jamaneurol.2017.0985","article-title":"Conversion to Parkinson disease in the PARS hyposmic and dopamine transporter-deficit prodromal cohort","volume":"74","author":"Jennings","year":"2017","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.parkreldis.2020.02.001_bib19","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1212\/WNL.0000000000001364","article-title":"Parkinson risk in idiopathic REM sleep behavior disorder: preparing for neuroprotective trials","volume":"84","author":"Postuma","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2020.02.001_bib20","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1093\/gerona\/glx081","article-title":"The prevalence of anosmia and associated factors among U.S. Black and white older adults","volume":"72","author":"Dong","year":"2017","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.parkreldis.2020.02.001_bib21","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/S1474-4422(15)00178-7","article-title":"Diagnosis of Parkinson's disease on the basis of clinical and genetic classification: a population-based modelling study","volume":"14","author":"Nalls","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.parkreldis.2020.02.001_bib22","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1093\/qjmed\/hcq142","article-title":"A basic smell test is as sensitive as a dopamine transporter scan: comparison of olfaction, taste and DaTSCAN in the diagnosis of Parkinson's disease","volume":"103","author":"Deeb","year":"2010","journal-title":"QJM"},{"key":"10.1016\/j.parkreldis.2020.02.001_bib23","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/mds.22899","article-title":"Cognitive-nigrostriatal relationships in de novo, drug-naive Parkinson's disease patients: a [I-123]FP-CIT SPECT study","volume":"25","author":"Nobili","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2020.02.001_bib24","doi-asserted-by":"crossref","first-page":"206 e229","DOI":"10.1016\/j.neurobiolaging.2010.09.004","article-title":"Interaction of caudate dopamine depletion and brain metabolic changes with cognitive dysfunction in early Parkinson's disease","volume":"33","author":"Polito","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.parkreldis.2020.02.001_bib25","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1002\/mds.25157","article-title":"Dopamine transporter imaging is associated with long-term outcomes in Parkinson's disease","volume":"27","author":"Ravina","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2020.02.001_bib26","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1212\/01.wnl.0000338632.00552.cb","article-title":"Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study","volume":"72","author":"Aarsland","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2020.02.001_bib27","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1001\/jamaneurol.2013.2110","article-title":"Prognosis of mild cognitive impairment in early Parkinson disease: the Norwegian ParkWest study","volume":"70","author":"Pedersen","year":"2013","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.parkreldis.2020.02.001_bib28","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1017\/S1355617713000295","article-title":"Cognitive change in newly-diagnosed patients with Parkinson's disease: a 5-year follow-up study","volume":"19","author":"Broeders","year":"2013","journal-title":"J. Int. Neuropsychol. Soc."},{"key":"10.1016\/j.parkreldis.2020.02.001_bib29","doi-asserted-by":"crossref","first-page":"3298","DOI":"10.1093\/brain\/awp244","article-title":"Markers of neurodegeneration in idiopathic rapid eye movement sleep behaviour disorder and Parkinson's disease","volume":"132","author":"Postuma","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2020.02.001_bib30","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1136\/jnnp-2015-311827","article-title":"Incident impulse control disorder symptoms and dopamine transporter imaging in Parkinson disease","volume":"87","author":"Smith","year":"2016","journal-title":"J. Neurol. Neurosurg. Psychiatry"}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802020300304?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802020300304?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:18:08Z","timestamp":1761178688000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802020300304"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":30,"alternative-id":["S1353802020300304"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2020.02.001","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-motor symptoms and striatal dopamine transporter binding in early Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2020.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}